Invitrogen™ Prasinezumab Humanized Recombinant Human Monoclonal Antibody

Description

Endotoxin level < 0.01EU/μg by LAL method Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8 °C for one week. Store at -20 to -80 °C for twelve months from the date of receipt.

Prasinezumab (PRX002/RG7935) is an investigational monoclonal antibody that targets alpha-synuclein, a protein that is believed to misfold and aggregate to form the protein structures that are highly implicated in Parkinson's disease pathology. Prasinezumab targets alpha-synuclein and is being developed through a worldwide collaboration with Roche as a potentially disease modifying therapy that is designed to slow or reduce the neurodegeneration associated with alpha-synuclein misfolding and/or its transmission.